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Integrins direct Src family kinases to regulate distinct 
phases of oligodendrocyte development
 
Holly Colognato,
 
1,2
 
 Shwetha Ramachandrappa,
 
1,2
 
 Inger M. Olsen,
 
1,2
 
 and Charles ffrench-Constant
 
1,2,3
 
1
 
Department of Pathology, 
 
2
 
Centre for Brain Repair, and 
 
3
 
Department of Medical Genetics, University of Cambridge, Cambridge CB21QP, England, UK
 
pecific integrins expressed on oligodendrocytes,
the myelin-forming cells of the central nervous sys-
tem, promote either differentiation and survival or
proliferation by amplification of growth factor signaling.
Here, we report that the Src family kinases (SFKs) Fyn
and Lyn regulate each of these distinct integrin-driven
behaviors. Fyn associates with 
 

 
6
 

 
1 and is required to
amplify platelet-derived growth factor survival signaling,
to promote myelin membrane formation, and to switch
neuregulin signaling from a phosphatidylinositol 3-kinase
to a mitogen-activated protein kinase pathway (thereby
changing the response from proliferation to differentiation).
S
 
However, earlier in the lineage Lyn, not Fyn, is required
to drive 
 

 
V
 

 
3-dependent progenitor proliferation. The
two SFKs respond to integrin ligation by different mecha-
nisms: Lyn, by increased autophosphorylation of a cata-
lytic tyrosine; and Fyn, by reduced Csk phosphorylation
of the inhibitory COOH-terminal tyrosine. These findings
illustrate how different SFKs can act as effectors for spe-
cific cell responses during development within a single
cell lineage, and, furthermore, provide a molecular mech-
anism to explain similar region-specific hypomyelination
in laminin- and Fyn-deficient mice.
 
Introduction
 
The development of complex tissues requires that cell migra-
tion, proliferation, differentiation, and survival be precisely reg-
ulated so that each occurs only at appropriate stages within each
cell lineage. This regulation is achieved by the integration of
multiple extracellular cues that act in concert with intrinsic de-
velopmental gene expression programs to control cell behavior,
but the mechanisms of integration remain poorly understood.
We have recently described a novel integrative mechanism for
growth factor and ECM signaling in oligodendrocytes, the my-
elinating cells of the central nervous system. At physiological
concentrations of PDGF, two orders of magnitude less than typ-
ically used for culture studies, the PDGF
 

 
 receptor (PDGF
 

 
R)
expressed on oligodendroglial cells does not stimulate prolifer-
ation directly, but rather activates associated 
 

 
V
 

 
3; this high
affinity integrin subsequently triggers downstream signaling
pathways after ECM binding (Baron et al., 2002). A similar
mechanism contributes to the survival of newly formed oligo-
dendrocytes: 
 

 
6
 

 
1 integrin is required for the amplification of
growth factor survival signaling that is necessary for the oligo-
dendrocytes’ survival at physiological PDGF concentrations
(Colognato et al., 2002). Thus, growth factor signaling is spa-
tially controlled by the location of ECM ligands such as 
 

 
2
chain–containing laminins found within axon tracts, thereby pro-
viding a mechanism for target-dependent survival of oligoden-
drocytes during development (Colognato et al., 2002). Similarly,
the switch observed in the integrin associated with PDGF
 

 
R,
from 
 

 
V
 

 
3 to 
 

 
6
 

 
1, may contribute to the temporal regulation
of growth factor signaling by changing the cell’s response from
proliferation to survival (Baron et al., 2002, 2003).
However, a key prediction is that each integrin would be
able to trigger associated signaling molecules whose effects are
specific for one component of cell behavior. Our current under-
standing of integrin signaling within developing systems has
not yet confirmed the identity of signaling molecules with the
required specificity. The Src family kinases (SFKs) are nonre-
ceptor tyrosine kinases that integrate external signals received
through both integrin and growth factor receptors and, thus, are
good candidates to transduce signals that regulate both integrin-
and growth factor–driven phases of oligodendrocyte develop-
ment. One of these, Fyn, is expressed throughout the brain, in
both neurons and glia, but the peak of its activity during develop-
ment can be correlated with myelination (Umemori et al., 1992;
Osterhout et al., 1999). Fyn may be involved in the oligodendro-
cyte differentiation process, because transgenic mice lacking Fyn
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activity are hypomyelinated (Umemori et al., 1994; Sperber et
al., 2001) and cultured oligodendrocytes from 
 
Fyn
 
 
 

 
/
 

 
 mice or
those expressing dominant-negative Fyn show defects in the
numbers of newly formed oligodendrocytes, as well as in the
formation of complex branches of myelin membrane (Oster-
hout et al., 1999; Sperber and McMorris, 2001). Furthermore,
mice deficient in the laminin 
 

 
2 chain have a similar region-
specific hypomyelination, suggesting that Fyn and laminins
may operate in the same signaling pathway, and that integrin
receptors may contribute to this pathway (Chun et al., 2003).
Another SFK, Lyn, is also expressed in oligodendrocytes, but
no function has been described. However, in the hematopoietic
lineage, 
 

 
1 integrin has been found in a complex with Lyn after
fibronectin (FN)-mediated adhesion (Miller et al., 1999), and it
was recently shown that 
 

 
1 and Src can be directly associated,
indicating that different cell types may regulate unique combi-
nations of SFK–integrin associations based on the cell func-
tions required (Arias-Salgado et al., 2003).
Distinct roles for Fyn and Lyn could provide a mecha-
nism that enables each integrin to have distinct functions in oli-
godendrocyte development. Here, we tested this hypothesis by
determining the associations among integrins, growth factor re-
ceptors, and the two SFKs, using siRNAs to knock down each
SFK and examine the effect in developing oligodendrocyte cul-
tures freshly isolated from the brain, and by examining the acti-
vation of each SFK by integrin signaling. We found that Lyn
and Fyn were associated with 
 

 
V
 

 
3 and 
 

 
6
 

 
1, respectively,
and that Lyn, but not Fyn, was required for PDGF-stimulated
proliferation of oligodendrocyte progenitors. However, at later
stages of differentiation Fyn, but not Lyn, was associated with
 

 
6
 

 
1 and was required for laminin-mediated amplification of
growth factor–mediated survival and for differentiation with
enhancement of myelin membrane formation. These results
suggest a model in which integrins determine the consequences
of growth factor signaling in oligodendrocytes via an associ-
ated SFK, and demonstrate how different SFKs can act within a
single cell lineage as effectors that are specific for individual
aspects of cell behavior and are able to integrate multiple up-
stream signaling cues.
 
Results
 
Generating SFK-deficient 
oligodendrocytes using small interfering 
RNA
 
Oligodendrocytes have been shown previously to express three
different SFKs: Fyn, Lyn, and Src (Umemori et al., 1992; Sper-
ber et al., 2001). We confirmed that primary rat oligodendro-
cytes expressed these kinases, and that their expression was
regulated in differentiating cells (Fig. 1 A). Progenitor cells
were withdrawn at day 0 from growth factors that promote
their division and prevent differentiation, and lysates were pre-
pared from cells grown in conditions that promote oligoden-
drocyte differentiation, at days 1, 2, 4, or 6. Fyn and Lyn
showed the highest levels of expression at days 2 and 4 of dif-
ferentiation, correlating with the transition from oligodendro-
cyte progenitors to newly formed oligodendrocytes. Src ex-
pression was relatively difficult to detect, except at earlier
stages (days 1 and 2), and was undetectable by day 6.
To investigate the roles of individual SFKs, we used pSU-
PER to drive expression of small interfering RNA (siRNA). We
performed Western blots on lysates of G418-resistant cells to
evaluate protein levels (Fig. 1, B and C). Blots using Fyn-spe-
cific antibodies showed that cells transfected with a Fyn-target-
ing construct, Fyn(
 

 
), had a decrease in Fyn protein (59 kD),
whereas cells transfected with the Lyn-targeting construct,
Lyn(
 

 
), had no change in Fyn expression. Conversely, blots us-
ing Lyn-specific antibodies showed a decrease in Lyn protein (53
and 56 kD) in Lyn(
 

 
)-transfected cells but not in Fyn(
 

 
) cells.
Transfection with control vectors had no effect on Fyn or Lyn
protein expression. Western blots using Src-specific antibodies
showed that Src(
 

 
) cells had reduced levels of Src protein,
whereas Src protein levels in Fyn(
 

 
) cells remained unchanged.
Loss of protein expression was also confirmed using im-
munohistochemistry. Because isolated progenitors expanded in
PDGF and FGF respond to growth factors and ECM differently
from the way progenitors that are freshly isolated from cortical
Figure 1. siRNA depletes Src family kinases in primary oligodendrocytes.
(A) Src family kinase (SFK) protein expression in oligodendrocytes differen-
tiated for 1, 2, 4, or 6 d after growth factor withdrawal. (B) SFK Western
blots of G418-selected progenitors transfected with Fyn and Lyn depletion
constructs. (C) Western blots of oligodendrocyte progenitors transfected
with Src depletion construct. (A–C) Blots were also probed with actin anti-
bodies as protein loading controls. (D) Immunostaining to visualize Fyn
protein in a mixed population containing YFP-transfected cells. Control
(left) and Fyn() (middle) micrographs depict newly differentiated oligo-
dendrocytes labeled with antibodies against Fyn (red) and GFP (green)
(arrowheads). Double-labeled cells do not appear in the Fyn()-transfected
population. (right) Control cells expressing late differentiation markers
MBP (red) and YFP (green) (arrows).
 DEVELOPMENTAL ROLES OF SRC FAMILY KINASES IN OLIGODENDROCYTES • COLOGNATO ET AL.
 
367
 
cultures respond, we avoided expansion in experiments exam-
ining cell behavior; instead, we evaluated a mixed population
in which the subset of transfected cells was identified by YFP
expression. Shown in Fig. 1 D are two cell populations that
have been transfected with different vectors: one expressed
YFP alone (control, left and right), and one expressed YFP and
Fyn siRNA (Fyn(
 

 
), middle). In controls (Fig. 1 D, left), many
cells expressed both Fyn and YFP (arrowheads), whereas in
Fyn(
 

 
) cells, the transfected cell population (YFP) and the
Fyn-expressing population were mutually exclusive. Control-
transfected cells (Fig. 1 D, right) had normal morphology and
differentiated identically to nontransfected oligodendrocytes,
as illustrated by cells labeled with myelin basic protein (MBP)
and GFP antibodies (arrows).
 
Lyn regulates integrin-specific 
proliferation, but not migration
 
To determine whether SFKs play a role in the responses of oli-
godendrocyte progenitors, we evaluated two essential functions
of progenitors, proliferation and migration, using cells in which
individual SFKs were depleted. PDGF is a mitogen for oligo-
dendrocyte progenitors, and the proliferative response seen at
physiological PDGF concentrations (0.1–1.0 ng/ml) can be
enhanced by 
 

 
V
 

 
3 integrin engagement (Baron et al., 2002).
We evaluated proliferation of SFK-depleted progenitors in the
presence of increasing amounts of PDGF and in the presence or
absence of the 
 

 
V
 

 
3 ligand FN (Fig. 2). With increasing
PDGF concentrations, proliferation increased equally well in
control and Fyn-, Lyn-, and Src-depleted progenitors grown on
non-integrin substrate poly-
 
D
 
-lysine (PDL; Fig. 2, left). How-
ever, proliferation of Lyn-depleted cells on the 
 

 
V
 

 
3 ligand
FN was reduced in response to physiological levels of PDGF
(Fig. 2, right; *, P 
 
 
 
0.05). In contrast, depletion of Fyn or Src
did not reduce PDGF-mediated proliferation on either sub-
strate. Proliferation of progenitors grown on the 
 

 
6
 

 
1 ligand
laminin-2 (Lm2) also increased with increasing PDGF; how-
ever, SFK depletion had no effect (not depicted).
Next, we tested whether progenitor migration in response
to PDGF also involves a role for Lyn. The migration of SFK-
depleted progenitor cells on ECM ligands was measured in the
presence of varying amounts of PDGF. Progenitors were con-
centrated in a drop of low melting temperature agarose to estab-
lish a defined starting point, and the distance between the aga-
rose boundary and each YFP
 

 
 cell was measured (Fig. 3). A
drop that contains Lyn-depleted cells migrating on FN in the
presence of 1 ng/ml PDGF is shown in Fig. 3 A. Unlike prolif-
eration, no difference in PDGF-mediated migration was ob-
served after the removal of Fyn, Lyn, or Src. The mean dis-
tances (micrometers) of migration on FN in response to 1 ng/ml
PDGF were 71.2 
 

 
 3.2 (control), 78.2 
 

 
 13.2 (Fyn(
 

 
)),
72.6 
 

 
 3.9 (Lyn(
 

 
)), and 73.0 
 

 
 14.3 (Src(
 

 
)) (Fig. 3 B).
Cells migrated further in response to 10 ng/ml PDGF; however,
no significant difference among different SFK-depleted cells
was observed: the mean migration distances (micrometers)
were 117.9 
 
 
 
5.6 (control), 126.2 
 
 
 
16.8 (Fyn(
 

 
)), 130.3 
 

 
2.2 (Lyn(
 

 
)), and 120.2 
 
 
 
14.2 (Src(
 

 
)). Progenitors on PDL
or Lm2 migrated less than cells on FN, but also exhibited no dif-
ference in their ability to migrate after SFK depletion (not de-
picted). Thus, oligodendrocyte progenitors have different require-
ments for Lyn during migration and proliferation in response to
the same growth factor (PDGF) and ECM stimulus (FN).
 
Newly formed oligodendrocytes require 
Fyn for laminin amplification of survival
 
As oligodendrocyte progenitors exit the cell cycle and differen-
tiate, they have an increased dependency on survival factors
such as PDGF and neuregulin (NRG) (Barres et al., 1993;
Canoll et al., 1996; Calver et al., 1998; Fernandez et al., 2000).
Laminins that are found in myelinating axon tracts can potenti-
ate the effects of these soluble survival factors (Frost et al.,
1999; Colognato et al., 2002). We evaluated the ability of newly
formed oligodendrocytes (defined by expression of the lineage
marker galactocerebroside [GalC]) to respond to survival fac-
tors in the presence of Lm2 after depletion of individual SFKs.
Figure 2. Progenitors require Lyn, but not Fyn or Src, for PDGF-mediated
proliferation on the V3 ligand. Oligodendrocyte progenitors exposed to
0, 0.1, 1, or 10 ng/ml PDGF for 24 h were evaluated for the percentage
of cells that incorporated BrdU. Profiles of control (black squares), Fyn-
depleted (gray diamonds), Lyn-depleted (gray triangles), and Src-depleted
(gray circles) cells are shown. On poly-D-lysine (PDL), all progenitors showed
a similar dose-dependent increase in BrdU incorporation. In contrast, Lyn-
depleted progenitors grown on the V3 ligand fibronectin (FN) showed re-
duced BrdU incorporation (*, P  0.05). Error bars represent SD. Figure 3. Progenitors do not require Lyn for PDGF-mediated migration.
Oligodendrocyte progenitors were concentrated in agarose drops and
stimulated to migrate using PDGF. (A) Micrograph depicting Lyn-deficient
cells (YFP) migrating on FN in response to 1 ng/ml PDGF. (left) Anti-
GFP; (right) phase. (B) Migration of SFK-deficient cells on FN in response
to 1 ng/ml PDGF at day 2. Each bar depicts the mean migration distance
of all YFP cells that have exited drops. Error bars represent SD.
 JCB • VOLUME 167 • NUMBER 2 • 2004368
 
Cells were differentiated for 4 d with increasing doses of PDGF
or NRG, and were evaluated for survival by TUNEL assays on
double-labeled GFP/GalC-positive cells (Fig. 4).
Newly formed oligodendrocytes grown on Lm2 ampli-
fied the survival-promoting effects of PDGF (Fig. 4 A, con-
trol). In contrast, Fyn-depleted cells grown on Lm2 did not
shift the dose–response to PDGF, such that survival in response
to 0.1 or 1.0 ng/ml PDGF (physiological levels) was signifi-
cantly lower than in control cells grown on Lm2 (Fig. 4 A, *,
P 
 
 
 
0.05 and **, P 
 
 
 
0.01). As described in Materials and meth-
ods, these assays were performed at a density of 20,000 cells/
well, but the same trend in response to Fyn depletion was ob-
served at lower plating densities of 2,500 and 10,000 cells/well
(unpublished data). Lyn depletion had a smaller effect on Lm2
amplification of PDGF survival, with a reduction in survival
only observed at 1.0 ng/ml PDGF (Fig. 4 A, *, P 
 
 
 
0.05). No
reduction in survival was observed at high, nonphysiological
levels of PDGF (10 ng/ml) that are not amplified by Lm2. Src
depletion did not affect survival on either substrate.
 
A laminin-mediated switch in NRG 
survival signaling requires Fyn
 
NRG-mediated survival is minimal when freshly isolated cells
are grown on PDL or FN; however, Lm2 amplifies NRG’s abil-
ity to mediate survival (Colognato et al., 2002). We observed a
robust amplification of NRG-mediated survival when control-
transfected newly formed oligodendrocytes were grown on Lm2
(Fig. 4 B, control). In contrast, Fyn-depleted cells on Lm2 did
not amplify NRG-mediated survival, and a significant reduction
in survival (Fig. 4 B, **, P 
 
 
 
0.01) was observed at all NRG
concentrations. However, Lyn-depleted cells grown on Lm2 re-
tained the ability to amplify NRG-mediated survival, and, as
with PDGF, depletion of Src had no effect. In cells grown on
PDL, Fyn and Lyn depletion had no significant effect on NRG-
mediated survival (not depicted), indicating that, as with PDGF,
the SFK plays a role in amplification of survival by the ECM
substrate rather than by the growth factor signal alone.
Laminin switches the preferred signaling pathways acti-
vated during NRG-mediated survival (Colognato et al., 2002).
Thus, on nonlaminin substrates, survival is sensitive to PI3K in-
hibition but insensitive to MAPK inhibition. This pattern is re-
versed by Lm2, such that survival is insensitive to PI3K inhibi-
tion but sensitive to MAPK inhibition (Fig. 5 A). Here, we
observed that the laminin-driven switch in NRG signaling did
not occur in Fyn-deficient cells, whereas Lyn-deficient cells re-
Figure 4. Newly formed oligodendrocytes require Fyn for laminin-medi-
ated amplification of survival. SFK-depleted progenitors were differenti-
ated on PDL or laminin-2 (Lm2) for 4 d with increasing amounts of the sol-
uble growth factors PDGF or neuregulin (NRG). Survival was evaluated
using TUNEL on a YFP/GalC double-positive cell population (transfected,
newly formed oligodendrocytes). Low, medium, and high amounts of
growth factors are depicted by light gray, dark gray, and black bars, re-
spectively. Error bars represent SD. (A) Fyn depletion caused a significant
shift in the PDGF dose–response curve when cells were differentiated on
Lm2 (low, *, P  0.05; medium, **, P  0.01). (B) NRG-mediated sur-
vival was significantly reduced in Fyn-depleted cells differentiated on Lm2
(**, P  0.01 for low, medium, and high concentrations of NRG),
whereas no significant reduction in survival occurred in Lyn-depleted cells.
Figure 5. Fyn is required for a laminin-mediated switch in NRG signaling
and for integrin activation to increase survival. (A) Survival of newly
formed SFK-depleted oligodendrocytes in the presence of the PI3K path-
way signaling inhibitor wortmannin (hatched bars), the MAPK pathway
signaling inhibitor PD098059 (light gray bars), or DMSO control (black
bars). Lm2 switches NRG-mediated survival from PI3K-sensitive to PI3K-
insensitive, and Fyn depletion, but not Lyn depletion, abolishes this effect.
Error bars represent SD. (B) Oligodendrocytes treated for 30 min with
NRG. PhosphoERK is enhanced by Lm2 in control cells, but not in Fyn()
cells. (C) Survival of newly formed SFK-depleted oligodendrocytes in the
presence (light gray bars) or absence (dark gray bars) of integrin-activat-
ing manganese. Integrin activation using manganese increased NRG-
mediated survival, and this increase was lost in the absence of Fyn, but
not of other SFKs. Error bars represent SD.
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mained able to switch. Wortmannin treatment of Fyn(
 

 
) cells
grown with NRG on Lm2 significantly reduced survival (**,
P 
 
 
 
0.01) compared with control and Lyn-depleted cells grown
on Lm2 (Fig. 5 A). Furthermore, Fyn depletion caused the cells
to become less sensitive to the MEK inhibitor PD098059 (Fig. 5
A). In addition, cells grown on Lm2 and treated with NRG show
enhanced phosphorylation of extracellular signal–related kinase
(ERK), yet do not amplify phosphorylation of Akt. Using a
modified electroporation technique to obtain a high percentage
of siRNA-positive cells (
 

 
50%), Western blots of oligodendro-
cyte lysates revealed that Fyn-depleted cells treated with NRG
were unable to amplify ERK phosphorylation (Fig. 5 B).
We showed previously that activation of 
 

 
V
 

 
3 integrin
using manganese is sufficient to amplify PDGF-driven prolif-
eration in progenitors, and we have recently shown that manga-
nese can also induce an amplification of PDGF-mediated sur-
vival similar to that seen using the 
 

 
6
 

 
1 ligand Lm2 (Baron et
al., 2002; Decker and ffrench-Constant, 2004). Activation is a
process in which the integrin subunits undergo conformational
changes that lead to an increase in affinity for ECM ligands
and/or to alterations in receptor clustering, both of which can
enhance associations with effector molecules and promote inte-
grin signaling (Travis et al., 2003). We determined whether in-
tegrin activation altered the requirement for SFKs during sur-
vival signaling; first, by evaluating whether activation altered
the survival of newly formed oligodendrocytes in the presence
of limiting concentrations of NRG, and second, by evaluating
whether depletion of SFKs could affect survival in the presence
of manganese (Fig. 5 C). With manganese, NRG-mediated sur-
vival increased in control (grown on PDL or Lm2) and Lyn-
depleted oligodendrocytes. However, Fyn-depleted oligoden-
drocytes treated with manganese did not increase survival in
response to NRG. This observation strengthens our conclusion
that Fyn, but not Lyn or Src, is required for integrin-mediated
amplification of survival signaling, and suggests that Fyn either
acts downstream of or helps to maintain integrin activation dur-
ing oligodendrocyte survival.
 
Differentiation on laminin requires Fyn
The same factors that are critical for newly formed oligoden-
drocytes to survive also regulate entry into the myelin-forming
stage of differentiation. To investigate whether SFKs regulate
Figure 6. Differentiation in response to laminin re-
quires Fyn. (A) Decreased MBP expression in cells
grown on laminin in the absence of Fyn. The per-
centage of SFK-depleted cells expressing the late
stage differentiation marker MBP was expressed rel-
ative to the percentage of MBP in control cells.
SFK-depleted cells grown on PDL (black bars) and on
Lm2 (gray bars) were compared at days 2 and 4 af-
ter growth factor withdrawal. Error bars represent SD.
(B) Myelin membrane classification scheme. Examples
of MBP-expressing cells are shown. Stages 1, 2, and
3 show increasing levels of process outgrowth and
branching, without myelin membrane, whereas stages
4, 5, and 6 show increasing levels of complexity and
myelin membrane. (C) Fyn-depleted cells have less
myelin membrane acquisition and complexity on Lm2
substrates. The percentage of cells within each cate-
gory is shown for SFK-depleted YFP/MBP double-pos-
itive cells. Oligodendrocytes differentiated on PDL or
Lm2 (control), black squares; Fyn(), light gray
squares; Lyn(), gray triangles; and Src(), dark
gray circles (*, P  0.050). Error bars represent SD.
(D) Typical MBP-expressing (control) and Fyn-depleted
oligodendrocytes grown on Lm2.
JCB • VOLUME 167 • NUMBER 2 • 2004370
the ability of the ECM to alter oligodendrocyte differentia-
tion, we evaluated MBP expression in the presence of inte-
grin ligands in SFK-depleted cells. The percentage of MBP-
expressing cells was determined, and the relative change
between SFK-deficient cells and control cells is shown in Fig.
6 A. In cells differentiating on PDL, depletion of Fyn, Lyn, or
Src had no effect on the percentage of cells that acquired MBP
expression by days 2 or 4 (Fig. 6 A, black bars). In contrast,
Fyn-depleted cells differentiated on Lm2 showed a large reduc-
tion in the percentage of cells expressing MBP, at both days 2
and 4 (Fig. 6 A, gray bars). However, Lyn- or Src-depleted cells
showed no change in differentiation on either substrate.
To further evaluate the cells that acquired MBP expres-
sion, we used a classification scheme to describe the morphol-
ogy and degree of myelin membrane formation in MBP cells
(Fig. 6 B). Categories 1, 2, and 3 were used to describe MBP
cells with increasing degrees of complex branched processes in
the absence of myelin membrane (low, medium, and high, re-
spectively), whereas categories 4, 5, and 6 were used to de-
scribe cells with increasing levels of myelin membrane (low,
medium, and high, respectively). Cells double-labeled with
MBP and GFP antibodies were assessed at days 2 and 4 and as-
signed to a myelin category (Fig. 6 C). A reduction in branch-
ing complexity and myelin membrane acquisition was seen in
Fyn-depleted cells (Fig. 6 C, light gray squares; *, P  0.05)
differentiated on Lm2 for 4 d. A typical Fyn-depleted, MBP
cell is shown in Fig. 6 D. In contrast, Lyn- and Src-depleted
cells formed complex myelin membranes as normal. None of
the SFK-depleted cells showed significant differences in my-
elin membrane formation when grown on the non-integrin sub-
strate PDL (Fig. 6 C) or on FN (not depicted).
Fyn associates with 61, whereas Lyn 
associates with PDGFR and V3 
integrin
Having shown that Lyn and Fyn regulate proliferation and sur-
vival/differentiation, respectively, we asked whether each SFK
was associated with the integrin–growth factor receptor com-
plexes responsible for these different stages of oligodendroglial
development. Using immunofluorescence microscopy, we de-
tected 61 and Fyn in newly formed oligodendrocytes in an
overlapping distribution (Fig. 7 A). Next, detergent lysates of
newly formed oligodendrocytes grown on PDL, Lm2, and FN
in the presence or absence of growth factors were evaluated by
immunoprecipitation for the formation of protein complexes
(Fig. 7, B–E). Antibodies specific for the 6 integrin subunit
isolated complexes containing Fyn, but not Lyn, and the 61–
Fyn association was independent of substrate or growth factor
stimuli (Fig. 7 B). Immunoprecipitations using Fyn antibodies
also revealed a potential association between Fyn and the
ErbB4 NRG receptor subunit (Fig. 7 C). This association was
difficult to detect but, interestingly, was only observed in cells
treated with NRG on non-integrin substrates. PDGFR immu-
noprecipitations revealed an association between PDGFR and
Lyn that, in the absence of PDGF, was most robust on FN but,
in the presence of PDGF, was also observed in cells grown on
PDL or Lm2 (Fig. 7 D). No association between Fyn and PDG-
FR was observed (unpublished data). Lyn immunoprecipita-
tions revealed an association between Lyn, but not Fyn, and the
V3 integrin that was also enhanced by FN but, in contrast to
the Lyn–PDGFR association, was not detected after PDGF
treatment (Fig. 7 E).
Distinct mechanisms of Fyn and Lyn 
activation by 61 and V3 ligands
We asked whether ligand binding by each integrin specifically
altered associated SFK activity. We tested this using antibodies
specific for two phosphorylated tyrosines within Src that also
recognize the following conserved tyrosine (Y) sites in Fyn and
Lyn: (1) Y418 (Y420 and Y397 in rat Fyn and Lyn, respec-
tively), which is an autophosphorylation site; and (2) Y527
(Y531 and Y508 in rat Fyn and Lyn, respectively), which is
phosphorylated by COOH-terminal Src kinase (Csk) to in-
activate the SFK. First, we used the antibody against Src
phosphoY418 to examine the phosphorylation of Fyn or Lyn
by oligodendrocyte precursors grown on PDL, Lm2, or FN
Figure 7. SFK associations with integrins and growth factors. (A) Newly
formed oligodendrocytes immunostained with antibodies against Fyn (red)
and 61 integrin (green). Merged panel is shown on the right. (B) Oligo-
dendrocyte lysates from cells differentiated on ECM substrates in the pres-
ence or absence of PDGF or NRG. Western blot on 6 integrin antibody
immunoprecipitation complexes to detect Fyn. (C) Western blot on Fyn
antibody immunoprecipitation complexes to detect ErbB4 NRG receptor
subunit. (D) Western blot on PDGFR antibody immunoprecipitation com-
plexes to detect Lyn. (E) Western blots on Lyn antibody immunoprecipitation
complexes to detect the 3 integrin subunit.
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(Fig. 8 A). We found that the catalytic tyrosine was phosphory-
lated on Fyn, independent of substrate. In contrast, on Lyn,
phosphorylation of Y397 was only seen in cells grown on the
V3 ligand FN, suggesting that this SFK was activated by
V3 and not by 61.
Next, we examined SFK activity in newly differentiated
oligodendrocytes. Fyn and Lyn are enriched in detergent-insolu-
ble lipid raft domains in oligodendrocytes, so we examined both
Triton X-100–insoluble and Triton X-100–soluble fractions in
both differentiated cells and progenitors. We confirmed that Fyn
was highly enriched in the insoluble pool at the oligodendrocyte
stage and additionally found that treatment with Lm2 had no ef-
fect on the ratios of Fyn and Lyn found in the insoluble pools
(Fig. 8 B). We observed that in freshly isolated progenitors
grown in PDGF, substantially less Fyn was found in the insolu-
ble pool compared with Lyn (Fig. 8 B), indicating that in prolif-
erating cells, less Fyn may be raft-associated than in more dif-
ferentiated cells. A high level of phosphorylation detected with
the antibody against Src phosphoY418 was observed within this
insoluble fraction in both progenitors and oligodendrocytes, and
Lm2 had no effect on this phosphorylation (Fig. 8 C). However,
Lm2 substrates did reduce the phosphorylation detected by anti-
bodies against phosphorylated negative regulatory Src Y527 in
the insoluble fraction of oligodendrocytes.
We found that oligodendrocytes express Csk, the kinase
that phosphorylates the COOH-terminal SFK negative regula-
tory site, and that levels of Csk within the SFK-containing in-
soluble fractions were decreased in cells grown on Lm2, but
only in oligodendrocytes, not in progenitors (Fig. 8 B). There-
fore, we conclude that the 61 ligand Lm2 alters Fyn activ-
ity by regulating the dephosphorylation of the inhibitory
COOH-terminal Y531, at least in part by down-regulation of
Csk, with the catalytic tyrosine (Y420) being unaffected by
Lm2 engagement. We also evaluated SFK phosphorylation in
cells grown on FN (Fig. 8 D). In contrast with our observa-
tions in cells grown on Lm2, we detected no change in
phosphoY527 immunoreactivity.
Two findings make it unlikely that a significant level of
the immunoreactivity detected by the antibody against phos-
phoY527 can be attributed to phosphorylation of the homolo-
gous inhibitory Y508 in Lyn. First, comparison of the soluble/
insoluble fractions in the precursors shows Lyn to be enriched
in the insoluble fraction, whereas phosphoY527 immunoreac-
tivity was detected entirely in the soluble fraction, where Fyn
and Csk are highly expressed. Second, we did not detect immu-
noreactivity using the antibody against Src phosphoY527 after
Lyn-specific pulldowns (unpublished data). We conclude that,
in contrast with Fyn, Lyn is activated by V3 ligands, result-
ing in the autophosphorylation of the catalytic Y397, whereas
the inhibitory Y508 remains unphosphorylated and does not
contribute to the regulation of Lyn.
Discussion
Myelinating oligodendrocytes provide a model system for un-
derstanding how ECM and growth factors regulate distinct as-
pects of cell behavior during development. We have shown
previously that changing interactions between integrins and
growth factor receptors within the membrane provide a mecha-
nism for temporal and spatial specificity of growth factor sig-
naling. Here, we identify the SFKs Fyn and Lyn as key effector
molecules within these integrin–growth factor receptor com-
plexes that selectively promote either proliferation or differen-
tiation/survival. As such, they serve both to integrate the extra-
cellular signals provided by ECM and growth factors and to
translate these signals into specific cell behaviors during devel-
opment. The illustration in Fig. 9 summarizes how these differ-
ent integrins regulate distinct phases of the oligodendrocyte
lineage by using distinct SFK partners and thereby ensuring
correct timing and location for oligodendrocyte proliferation,
survival, and, ultimately, myelin formation. In this model, the
key association necessary for the specificity of each SFK is
with the integrin, rather than with the growth factor receptor. In
support of this, a role for SFKs in integrin signaling is well es-
Figure 8. SFK activity is regulated by laminin in differentiating oligoden-
drocytes, not progenitors. (A) Active Lyn is detected in response to the
V3 ligand FN. Immunoprecipitation complexes using antibodies against
Fyn, Lyn, or control mouse IgG () were evaluated by Western blot for the
presence of autophosphorylated SFK phosphoY418. (B) Expression and
solubility of Fyn, Lyn, and COOH-terminal Src kinase (Csk) change during
oligodendrocyte lineage progression and in response to Lm2. Western
blots were performed using antibodies specific for SFKs and SFK regula-
tory kinase Csk. S, Triton X-100–soluble protein; I, Triton X-100–insoluble
protein. Blots were also probed with actin antibodies as protein loading
controls. (C) Phosphorylation of the SFK negative regulatory site is reduced
by laminin in oligodendrocytes, not progenitors. The same lysates as in B
were used, but Western blots were analyzed using antibodies against two
SFK sites: phosphoY418 (catalytic) and phosphoY527 (COOH-terminal
negative regulatory). (D) FN does not alter phosphorylation of the SFK
negative regulatory site. Lysates of progenitors and oligodendrocytes
grown on control substrate PDL or on the V3 ligand FN. Western blots
were performed using SFK antibodies specific for phosphoY418 (catalytic)
and phosphoY527 (COOH-terminal negative regulatory). Blots were also
probed with actin antibodies as protein loading controls. (A–D) In the ab-
sence of ECM ligands, cells were grown on non-integrin substrate PDL.
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tablished, whereas a link between SFK signaling and PDGFR
signaling remains less clear. Triple gene knockouts revealed
that Src, Yes, and Fyn were dispensable for PDGF-mediated
signaling in fibroblasts, but necessary for several ECM-medi-
ated functions (Klinghoffer et al., 1999). And, although PDGF
deficiency leads to hypomyelination during development, this
defect occurs in regions of the central nervous system that are
unaffected in Fyn / mice (Fruttiger et al., 1999). Together,
these findings are consistent with a model in which growth fac-
tor stimulation in the absence of integrin ligation is not suffi-
cient to activate a requirement for SFK.
An important component of the proposed model is the
selectivity for particular cell functions of two or more SFKs
expressed in a given cell type. Previous work in T cells has
shown how two SFKs expressed in these cells, Lck and Fyn,
both contribute to development. Lck / mice show a failure
of early thymocyte differentiation, whereas Fyn / mice are
normal, with Fyn being able to compensate partially for the
loss of Lck. In mature T cells, both Lck and Fyn are associ-
ated with the T cell receptor, and phosphorylation induced by
T cell receptor signaling is mediated by either SFK, depend-
ing on the targets. However, a high (but not complete) degree
of compensation in the T cell lineage is observed in SFK
knockout mice. In oligodendrocytes, each SFK appears to
have a more unique and distinct role than in mature T cells
and is associated with different membrane signaling com-
plexes. However, in knockout mice compensatory mecha-
nisms may develop, as is seen in Fyn null mice where Src is
up-regulated; therefore, we feel that shorter-term knockdowns
using siRNA are valuable for examining the requirement of
Fyn in the absence of compensation (Sperber et al., 2001).
We found that, in addition to having distinct integrin
associations, Fyn and Lyn are activated by different molecu-
lar mechanisms. We observed that oligodendrocytes express
Csk, a kinase that negatively regulates the function of SFKs
(Schmedt et al., 1998). Csk expression was highest in progeni-
tors, and its down-regulation in oligodendrocytes grown on
Lm2 correlated with reduced phosphorylation of the negative
regulatory tyrosine in Fyn. Laminin may influence the activity
of Csk directly, such as by reducing Csk levels or Csk accessi-
bility, or indirectly by accelerating the differentiation process
during which Csk activity is modulated. Preliminary data sug-
gest that oligodendrocytes express Csk binding protein, a trans-
membrane molecule that has been shown in T cells to target
Csk to the plasma membrane and direct a negative feedback
loop for SFK signaling (Kawabuchi et al., 2000). Developmen-
tally regulated changes in Csk binding protein levels could,
therefore, alter Csk activity. Another possible mechanism for
an integrin-dependent change in SFK activity would be regula-
tion of the availability or activity of phosphatases such as re-
ceptor protein tyrosine phosphatase, which has been shown to
regulate SFKs in an integrin-dependent manner in fibroblasts
(von Wichert et al., 2003).
The loss of phosphorylation of Fyn tyrosine 531 triggered
by laminin was associated with a switch from PI3K to MAPK
NRG survival signaling. This switch in signaling has signifi-
cant consequences for the development of the oligodendrocyte
lineage, in which NRG signaling alone has been shown to stim-
ulate PI3K signaling and keep oligodendrocytes in a differenti-
ation-arrested state (Canoll et al., 1999). We have shown previ-
ously that integrin-mediated contact with axons is an important
regulatory mechanism for triggering oligodendrocytes to sur-
vive and to complete the differentiation program (Colognato et
al., 2002). Csk may play an instructive role in this switch, be-
cause Csk null fibroblasts grown on laminin-10 show increased
MAPK signaling, whereas PI3K signaling is decreased under
these circumstances (Gu et al., 2003). Preliminary data using
Csk siRNA indicate that when Csk is decreased, Fyn Y531
phosphorylation is reduced and newly formed oligodendro-
cytes survive better than they do in control cells. Therefore, a
prediction from the current study is that reducing Csk expres-
sion or activity may also help trigger myelination in the stalled
preoligodendrocytes that have been observed in demyelinated
multiple sclerosis lesions (Chang et al., 2002).
In contrast, we did not observe phosphorylation of the
negative regulatory tyrosine in Lyn, indicating that Csk may
not regulate Lyn activity in oligodendrocytes. Instead, we ob-
served that phosphorylation of a catalytic tyrosine was in-
creased when cells were grown on V3 substrates. The ability
of Csk to regulate Fyn but not Lyn may result from the distri-
bution of Csk and from the SFKs within lipid raft membrane
microdomains. Both Fyn and Lyn are associated with lipid rafts
in oligodendrocytes (Kramer et al., 1999). Lipid microdomains
are more ordered regions of the plasma membrane that are
highly enriched in cholesterol and glycosphingolipids and,
thus, are insoluble in many detergents. These microdomains
are thought to act as signaling platforms that can sequester or
segregate signaling molecules, including integrin receptors. In-
Figure 9. Model for integrin regulation of SFK activity during
oligodendrocyte lineage progression. In oligodendrocyte progen-
itors, Lyn is associated with the PDGFR–V3 integrin complex
and contributes to proliferation signaling. Catalytic Y397 of Lyn
(orange) is phosphorylated after V3 integrin ligation. Fyn is
maintained in the inactive state by Csk phosphorylation of Fyn-
inhibitory COOH-terminal Y531 (yellow). After axonal contact
and ligation by 61 of the 2 chain laminins expressed in my-
elinating axon tracts, Lyn dissociates from the integrin–growth
factor complex and Csk is downregulated, reducing Fyn phos-
phorylation at Y531 and promoting Fyn activity. Active Fyn–61
complexes can then trigger PI3K and MAPK signaling, depend-
ing on the ligand binding of PDGFR and ErbB2/4 receptors, re-
spectively, thereby promoting oligodendrocyte survival, differen-
tiation, and myelin formation.
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deed, laminin causes a redistribution of integrin 61 to rafts
in newly formed oligodendrocytes, in which PDGF-mediated
survival signaling becomes dependent on the integrity of lipid
raft domains (Baron et al., 2003). We confirmed that Fyn and
Lyn are detergent insoluble in differentiated oligodendrocytes,
but found that Fyn was predominantly detergent soluble in oli-
godendrocyte progenitors stimulated with PDGF. This indi-
cates that Fyn may be excluded from rafts in proliferating cells.
A differential lipid raft association for Fyn and Lyn would pro-
vide a mechanism for ensuring that Csk, which is also found in
the soluble, nonraft pool, is available to inactivate Fyn, but not
Lyn, in proliferating progenitors.
Previous studies have shown that mice lacking Fyn or
Fyn kinase activity are hypomyelinated in the brain (Umemori
et al., 1994; Sperber et al., 2001). This is believed to be an oli-
godendrocyte-intrinsic defect because oligodendrocytes with
altered or absent Fyn activity differentiate defectively in cul-
ture (Osterhout et al., 1999; Umemori et al., 1999; Sperber and
McMorris, 2001; Liang et al., 2004). Expression of dominant-
negative Fyn resulted in morphological defects such as reduced
process outgrowth, whereas Fyn null cells had a reduced pro-
pensity to differentiate but exhibited normal morphology. Fyn
has been shown to activate p190RhoGAP, and expression
of dominant-negative or constitutively active forms of the
RhoGTPases Rho, Rac1, and cdc42 perturbs oligodendrocyte
process formation, suggesting that these GTPases are one set of
downstream targets for Fyn in the oligodendrocyte lineage
(Wolf et al., 2001; Liang et al., 2004). Mice deficient in the
laminin 2 subunit also have a hypomyelination defect, similar
in regional specificity to that in Fyn null mice (Chun et al.,
2003). Laminin- and Fyn-deficient mice are both hypomyeli-
nated in the forebrain and optic nerve, but have normal-appear-
ing myelin in the spinal cord. Furthermore, the expression of
laminin associated with axon tracts correlates with and peaks
with myelination, as does Fyn activity (Umemori et al., 1994;
Powell et al., 1998; Farwell and Dubord-Tomasetti, 1999; Os-
terhout et al., 1999; Colognato et al., 2002). These similarities
in phenotype and expression pattern can be explained by our
current findings showing that the laminin receptor 61 inte-
grin is constitutively associated with Fyn, and that Fyn is re-
quired for laminin to amplify differentiation and survival in re-
sponse to PDGF and NRG.
Several molecules have been proposed to regulate Fyn in
oligodendrocytes. Antibody-mediated clustering of the cell
surface molecule myelin-associated glycoprotein (MAG) was
found to increase Fyn kinase activity (Umemori et al., 1994).
However, MAG null mice do not have gross myelination de-
fects but instead are characterized by subtle defects in myelin
structure and periaxonal organization (Montag et al., 1994; Li et
al., 1998). MAG/Fyn double knockout mice are more severely
hypomyelinated than Fyn knockout mice, suggesting that the
relationship between MAG and Fyn is complex and that the two
molecules may operate in different signaling pathways (Biffiger
et al., 2000). The GPI-anchored IgG superfamily molecule F3/
contactin has also been proposed to regulate Fyn, because anti-
body-mediated clustering of F3/contactin in an oligodendrocyte
cell line, Oli-neu, increased Fyn kinase activity (Kramer et al.,
1999). However, like MAG null mice, F3 null mice do not have
a hypomyelination phenotype similar to that of the Fyn null
mice (Berglund et al., 1999). Therefore, Fyn may be able to ac-
tivate multiple signaling pathways within the oligodendrocyte.
An important question for further studies is to identify the
mechanism by which adaptor and other molecules regulate the
specific patterns of SFK association with the different receptors.
Materials and methods
siRNA
siRNAs were expressed using a modified version of the pSUPER plasmid,
provided by Jonathan Pines and Claire Aquaviva (University of Cam-
bridge, Cambridge, UK), in which YFP expression was driven from a CMV
promoter (Brummelkamp et al., 2002). A neomycin resistance cassette
(CLONTECH Laboratories, Inc.) was inserted to allow G418 selection of
transfected cells. Several different 19-nucleotide target sequences within rat
Fyn, Lyn, and Src cDNA were chosen according to the guidelines of
AA(N19)TT, or AA(N19)XX as a second choice (Tuschl, 2002). The follow-
ing target sequences were used: Fyn, 5-GCAGGACAGAAGATGACCT-
3; Lyn, 5-GCCTGGACAATGGTGGTTA-3; and Src, 5-TTCAACAGCCT-
GCAGCAGC-3. Oligonucleotide pairs 5-GATCCCC(N19)TTCAAG-
AGA(N19-rev-comp)TTTTTGGAAA-3 and 5-AGCTTTTCCAAAAA(N19)-
TCTCTTGAA(N19-rev-comp)GGG-3 were annealed and phosphorylated,
and then they were ligated into pSUPER/YFP digested with BglII and Hind-
III. Plasmids containing the correct insert were identified using an EcoRI
and HindIII restriction digest, and were sequenced. After selection of trans-
fected cells, Western blot analysis on protein levels was used to evaluate
constructs, and the most effective construct was subsequently used to de-
plete each mRNA. Controls used included empty vector, nonfunctional tar-
geting vectors, and scrambled targets.
Survival assay
8-well chamber slides (Nunc) were coated for 4 h at 37C with PDL
(Sigma-Aldrich), FN, or Lm2. Each well received 20,000 progenitors sus-
pended in SATO’s medium. 1 h after attachment, the indicated growth
factors were added and the cells were differentiated for 4 d. For PDGF as-
says, 0.1, 1.0, or 10 ng/ml PDGF was included, and for NRG assays, 1,
10, or 100 ng/ml NRG was included. Immunostaining using mouse anti-
GFP and rabbit anti-GalC antibodies was used to identify transfected,
newly formed oligodendrocytes. TUNEL using indirect immunofluores-
cence was used to visualize nicked DNA according to the manufacturer’s
instructions (Apoptag). In each well, a minimum of 100 GFP/GalC dou-
ble-positive cells were scored for TUNEL. Cell survival was determined by
the percentage of TUNEL-negative cells in the GFP/GalC double-positive
population. To compare different experiments, the percent change in cell
survival above or below the internal control (survival on PDL with no treat-
ment or growth factors) was calculated. Experiments were performed a
minimum of three times and the mean percent changes and SDs were cal-
culated. Statistical significance was determined using the paired t test.
Migration assay
Transfected progenitors were suspended in 10 	l SATO defined medium
plus PDGF and FGF. The volume of the cell suspension was measured and
one third of the volume of 1% low melting temperature agarose (prepared
in sterile PBS and equilibrated to 37C) was added. 1.5-	l drops of cell–
agarose suspension were added to the center of PDL-coated 8-well cham-
ber slides. The drops were incubated at 4C for 15 min to solidify aga-
rose, and then flooded with 0.2 ml SATO medium with 0, 1, or 10 ng/ml
PDGF and 10 ng/ml FN or Lm2. At day 2, cells were fixed with methanol
and immunostained with GFP antibodies to detect transfected cells. The
migration distance from the agarose drop boundary was measured on
captured images using OpenLab image software. For each experiment, all
transfected cells within four drops were measured and averaged for each
growth factor/ECM condition. Each experiment was performed at least
three times and a representative experiment is shown.
Proliferation assay
8-well Permanox chamber slides were coated for 4 h at 37C with PDL, FN,
or Lm2. Slides were blocked in PBS containing 0.5% heat-inactivated BSA
for 30 min and washed with PBS. Progenitors (20,000 per well) in DME
were allowed to attach for 1 h, and then an equal volume of DME contain-
ing BrdU and PDGF was added. Final concentrations were 0, 0.1, 1, and
JCB • VOLUME 167 • NUMBER 2 • 2004374
10 ng/ml for PDGF and 10 	M for BrdU. At 24 h, cells were washed and
fixed in methanol, immunofluorescence was performed with antibodies to
GFP to visualize YFP-transfected cells and to BrdU to visualize cells that
have entered S phase, and cells were stained with Hoechst to visualize nu-
clei. BrdU incorporation was defined as the percentage of healthy GFP
cells that were positive for BrdU. Each experiment was repeated at least
three times, with individual conditions performed in duplicate.
Cell culture
Disassociated rat neonatal cortices were cultured (at 37C in 7.5% CO2)
in DME with 10% FCS on PDL-coated flasks. By day 10, mixed glial cul-
tures were obtained, consisting of oligodendrocyte precursor cells and mi-
croglia growing on an astrocyte monolayer. Purified oligodendrocyte
precursor cells were isolated using a modification of the mechanical disso-
ciation and differential adhesion method described by McCarthy and de
Vellis (1980).
Transfection
Overnight incubation with lipid carrier FUGENE (Roche) was used to in-
troduce 5 	g plasmid DNA per 75-cm2 flask of mixed glial cultures.
Next, oligodendrocyte progenitors were purified by mechanical dissocia-
tion, and then they were selected in 400 	g/ml G418 with 10 ng/ml
PDGF and FGF to prevent differentiation and maintain proliferation. In
functional assays (survival, proliferation, migration, and differentiation),
progenitors were not selected and were plated directly in 8-well chamber
slides for analysis with no previous growth factor treatment. Transfected
cells (typically 10%) were visualized by YFP fluorescence. Cells pre-
pared for biochemistry were transfected using Nucleofector electropora-
tion system according to the manufacturer’s instructions with efficiencies
of 50% (Amaxa).
Protein analysis
Cells were washed with ice-cold PBS and lysed in 1% Triton X-100, 10
mM Tris, pH 7.4, 5 mM EDTA, and 150 mM NaCl on ice. Cells were
scraped and transferred to microfuge tubes and placed on ice for 15 min.
Lysates were centrifuged at 14,000 rpm to separate detergent-insoluble
and -soluble material. The Triton-insoluble pellet was solubilized in 10 mM
Tris and 1% SDS by trituration through a 21-gauge needle. Before immu-
noprecipitations, lysates were prepared as above but incubated at 37C
to solubilize lipid raft-associated proteins. Protein concentration was deter-
mined by protein assay (Bio-Rad Laboratories) and lysates were boiled for
5 min in Laemmli solubilizing buffer and 3% -mercaptoethanol. Proteins
were separated by SDS-PAGE using 7.5% or 10% acrylamide minigels
(Bio-Rad Laboratories) and blotted onto 0.45 	m nitrocellulose. Mem-
branes were blocked for 1 h in 0.1% Tween 20 and TBS (TBS-T) contain-
ing either 5% milk or 5% BSA, and then in primary antibodies in blocking
buffer overnight at 4C. Membranes were washed in TBS-T, incubated for
1 h in HRP-conjugated secondary antibodies (Amersham Biosciences),
washed again in TBS-T, and developed using chemiluminescence. For im-
munoprecipitation of protein complexes, lysates were incubated with anti-
bodies and protein A/G beads (Santa Cruz Biotechnology, Inc.) at 4C
overnight on a rotating wheel. Bead immune complexes were washed four
times and prepared for electrophoresis and Western blotting.
Immunocytochemistry and image acquisition
To detect YFP in fixed cells, we incubated the cells for 10 min in PBS con-
taining 3% PFA and 2% sucrose, and then performed immunocytochemis-
try with GFP antibodies (Molecular Probes) in PBS containing 0.4% BSA
and 0.1% Triton X-100. For double immunofluorescence, additional pri-
mary antibodies were included to detect MBP, GalC, CNPase, or Fyn, fol-
lowed by FITC- and TRITC-labeled donkey secondary antibodies. To visu-
alize Fyn and the 6 integrin subunit, we fixed cells with methanol for 5
min at 20C. Slides were mounted in Immunofluor (ICN Biomedicals)
and evaluated at room temperature using an Axioplan fluorescence mi-
croscope (Carl Zeiss MicroImaging, Inc.) fitted with 10
 eyepiece magni-
fication using 20
 (0.5 NA) and 40
 (0.75 NA) objectives. Images
were acquired using a digital camera (model C4742-95; Hamamatsu)
and imaging software (OpenLab) and were exported as TIFF files to
Adobe Photoshop.
Analysis of myelin membrane morphology
Oligodendrocytes transfected with siRNA constructs were differentiated
for 2 or 4 d in Sato’s medium with 0.5% FCS (differentiation medium).
YFP-positive cells were evaluated for the expression of MBP using immuno-
cytochemistry and graded according to morphological characteristics and
degree of myelin membrane formation (Results).
Reagents
Reagents were obtained from Sigma-Aldrich unless otherwise indicated.
Antibodies. The following rabbit polyclonal antibodies were used:
GalC, Fyn, PDGFR, and ErbB4 NRG receptor subunit (Santa Cruz Bio-
technology, Inc.); SFK phosphoY527 and phosphoY418 (Biosource Inter-
national); GFP (Molecular Probes); total ERK (New England Biolabs, Inc.);
and 3 integrin subunit (CHEMICON International). The following mouse
monoclonals were used: GFP; Fyn, and Csk (Transduction); pp60src (On-
cogene Research Products); a rat mAb against MBP (Serotec); a hamster
IgM against 1 integrin (BD Biosciences); and FITC or TRITC donkey sec-
ondary antibodies (Jackson ImmunoResearch Laboratories). For triple
immunofluorescence, aminomethylcoumarin-streptavidin (Vector Laborato-
ries) was used to detect biotin-conjugated secondary antibodies.
Proteins. Human recombinant PDGF-A and FGF-2 (PeproTech) were
used at 10 ng/ml, except where otherwise indicated. The active compo-
nent of NRG-1 was a recombinant protein comprising the EGF-like domain
(Neomarkers). PDL, FN, and human placental laminin, a mixture of lami-
nins that is primarily Lm2, were used at 10 	g/ml.
Other chemicals. Inhibitors (Calbiochem) were suspended in DMSO
and used at 50 nM (wortmannin) and at 25 	M (PD098059). In control
wells, the equivalent volume of DMSO was added. Manganese was used
at 50 	M.
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